rac,cis-Cevimeline Hydrochloride Salt
Share product
- structure.search.product.name rac,cis-Cevimeline Hydrochloride Salt
- Product Code: TRC-C283500
- CAS Number: 107220-28-0
- Brand: TRC
Product Overview
Product Code
TRC-C283500
CAS Number
Product Format
Neat
Molecular Formula
C10 H17 N O S . Cl H
Molecular Weight
235.77
API Family
Cevimeline HydrochlorideProduct Categories
Alternate CAS Number
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
Email download link
{{ errors.first('RequestCoaForm.lotNumber') }}
{{ errors.first('RequestCoaForm.requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('SendDownloadCoaLinkForm.coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('RequestSdsForm.selectedRegion') }}
{{ errors.first('RequestSdsForm.sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Cevimeline Hydrochloride Salt
CAS Number
107220-28-0
Molecular Formula
C10 H17 N O S . Cl H
Molecular Weight
235.77
Accurate Mass
235.0798
SMILES
Cl.C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3
InChI
InChI=1S/C10H17NOS.ClH/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11;/h8-9H,2-7H2,1H3;1H/t8-,10-;/m1./s1
IUPAC
(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane];hydrochloride
Alternate CAS Number
Free amine: 107233-08-9
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Format
Neat
API Family
Product Description
A novel muscarinic M1 and M3 receptor agonist. Sialagogue.
References: Masunaga, H., et al.: Eur. J. Pharmacol., 339, 1 (1997), Arisawa, H., et al.: Arzneim.-Forsch., 52, 14 (2002), Yasuda, H., et al.: Clin. Drug Invest., 22, 67 (2002), Ono, M., et al.: Am. J. Ophthalmol., 138, 6 (2004),